scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043619512 |
P356 | DOI | 10.1186/GB-2012-13-12-R112 |
P953 | full work available at URL | https://europepmc.org/articles/PMC3580410 |
https://europepmc.org/articles/PMC3580410?pdf=render | ||
https://genomebiology.biomedcentral.com/counter/pdf/10.1186/gb-2012-13-12-r112 | ||
https://link.springer.com/article/10.1186/gb-2012-13-12-r112/fulltext.html | ||
https://link.springer.com/content/pdf/10.1186/gb-2012-13-12-r112.pdf | ||
P932 | PMC publication ID | 3580410 |
P698 | PubMed publication ID | 23228031 |
P5875 | ResearchGate publication ID | 233890588 |
P50 | author | Lincoln Stein | Q6551037 |
P2093 | author name string | Guanming Wu | |
P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
Applied Bioinformatics | Q15754366 | ||
WGCNA: an R package for weighted correlation network analysis | Q21284194 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator | Q24564251 | ||
PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium | Q24644341 | ||
PID: the Pathway Interaction Database | Q24656193 | ||
Prognostic value of proliferation in invasive breast cancer: a review | Q24672660 | ||
Semi-supervised methods to predict patient survival from gene expression data | Q24804682 | ||
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts | Q25257621 | ||
Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
The KEGG resource for deciphering the genome | Q27860687 | ||
A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
The human CENP-A centromeric nucleosome-associated complex | Q28235264 | ||
Reactome: a database of reactions, pathways and biological processes | Q28298042 | ||
Network medicine: a network-based approach to human disease | Q29547462 | ||
Discovering regulatory and signalling circuits in molecular interaction networks | Q29614951 | ||
Oncogenic pathway signatures in human cancers as a guide to targeted therapies | Q29615526 | ||
Interactome networks and human disease | Q29615773 | ||
Network-based classification of breast cancer metastasis | Q29616384 | ||
A general framework for weighted gene co-expression network analysis | Q29617580 | ||
''R"--project for statistical computing | Q29618640 | ||
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 | ||
Application of z-score transformation to Affymetrix data | Q30929101 | ||
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome | Q33359495 | ||
A human functional protein interaction network and its application to cancer data analysis | Q33581341 | ||
Aurora kinase inhibitors--rising stars in cancer therapeutics? | Q33647643 | ||
CAERUS: predicting CAncER oUtcomeS using relationship between protein structural information, protein networks, gene expression data, and mutation data | Q33869027 | ||
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study | Q33969308 | ||
Gene expression-based prognostic signatures in lung cancer: ready for clinical use? | Q33988433 | ||
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome | Q34058091 | ||
Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles | Q34071483 | ||
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. | Q34433540 | ||
Dynamic modularity in protein interaction networks predicts breast cancer outcome | Q34934057 | ||
Subnetwork state functions define dysregulated subnetworks in cancer | Q35070492 | ||
Cancer biomarkers: a systems approach | Q36561609 | ||
Survival-related profile, pathways, and transcription factors in ovarian cancer | Q37081275 | ||
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer | Q37107395 | ||
Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival | Q37249243 | ||
A systems biology view of cancer | Q37434945 | ||
Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel | Q37862646 | ||
Clinical practice. Breast-cancer screening | Q37931934 | ||
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer | Q39961166 | ||
Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines | Q40612612 | ||
Regression Models and Life-Tables (with discussion) | Q41363019 | ||
Simple decision rules for classifying human cancers from gene expression profiles | Q41735339 | ||
Optimally discriminative subnetwork markers predict response to chemotherapy | Q42762256 | ||
p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer. | Q44095323 | ||
Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer | Q44846520 | ||
Cell cycle dysregulation influences survival in high risk breast cancer patients | Q45225407 | ||
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer | Q51929705 | ||
Gene expression signature with independent prognostic significance in epithelial ovarian cancer | Q80908361 | ||
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer | Q81561698 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gene expression profiling | Q1502169 |
P304 | page(s) | R112 | |
P577 | publication date | 2012-12-10 | |
P1433 | published in | Genome Biology | Q5533480 |
P1476 | title | A network module-based method for identifying cancer prognostic signatures | |
P478 | volume | 13 |
Q31093592 | A New Approach for Identification of Cancer-related Pathways using Protein Networks and Genomic Data. |
Q64256232 | A data-driven interactome of synergistic genes improves network-based cancer outcome prediction |
Q37390796 | A network-pathway based module identification for predicting the prognosis of ovarian cancer patients |
Q52147578 | A novel stem cell culture model of recurrent glioblastoma. |
Q30301043 | A pan-cancer analysis of prognostic genes |
Q34421629 | A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components |
Q92639496 | A pipeline to create predictive functional networks: application to the tumor progression of hepatocellular carcinoma |
Q28392301 | Altered lipid metabolism in the aging kidney identified by three layered omic analysis |
Q57046166 | An Improved Method for Prediction of Cancer Prognosis by Network Learning |
Q30920959 | Analyzing large gene expression and methylation data profiles using StatBicRM: statistical biclustering-based rule mining |
Q33816298 | Biological mechanisms discriminating growth rate and adult body weight phenotypes in two Chinese indigenous chicken breeds |
Q37736572 | Breast tumor subgroups reveal diverse clinical prognostic power |
Q24305288 | CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors |
Q96609471 | CODC: a Copula-based model to identify differential coexpression |
Q39119280 | Combined gene expression and proteomic analysis of EGF induced apoptosis in A431 cells suggests multiple pathways trigger apoptosis. |
Q54956414 | Comparisons of gene coexpression network modules in breast cancer and ovarian cancer. |
Q36343306 | Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression |
Q47941020 | Comprehensive analysis of long noncoding RNA-mRNA co-expression patterns in thyroid cancer |
Q37665607 | Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers |
Q36413098 | Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. |
Q36094642 | Context-specific functional module based drug efficacy prediction |
Q38685579 | Disease gene classification with metagraph representations |
Q36170782 | Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation |
Q61805560 | EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma |
Q35359098 | ENCAPP: elastic-net-based prognosis prediction and biomarker discovery for human cancers |
Q91697612 | Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types |
Q34788919 | Finding gene regulatory network candidates using the gene expression knowledge base |
Q39992601 | FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks |
Q58743681 | G2Vec: Distributed gene representations for identification of cancer prognostic genes |
Q43654815 | Gene expression information improves reliability of receptor status in breast cancer patients |
Q38113300 | Genome variation and personalized cancer medicine |
Q38791499 | Genomic analyses identify molecular subtypes of pancreatic cancer |
Q42739783 | HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery |
Q57288911 | IL-6 mediates ER expansion during hyperpolarization of alternatively activated macrophages |
Q36232146 | Identification and evaluation of network modules for the prognosis of basal-like breast cancer |
Q64074539 | Identification of , and as Novel Prognostic Signatures in Gallbladder Cancer Using Network-Based Module Analysis |
Q41557019 | Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm |
Q33697833 | Identification of breast cancer prognostic modules based on weighted protein-protein interaction networks |
Q37520344 | Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network |
Q49363717 | Identification of prognostic signature in cancer based on DNA methylation interaction network |
Q38920443 | Identifying differentially coexpressed module during HIV disease progression: A multiobjective approach |
Q38725310 | Identifying prognostic signature in ovarian cancer using DirGenerank |
Q34003648 | Identifying the gene signatures from gene-pathway bipartite network guarantees the robust model performance on predicting the cancer prognosis |
Q42696721 | Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers |
Q46989285 | Including network knowledge into Cox regression models for biomarker signature discovery |
Q60923564 | Integrating node embeddings and biological annotations for genes to predict disease-gene associations |
Q26999069 | Integrative analysis of cancer imaging readouts by networks |
Q93116509 | Label propagation defines signaling networks associated with recurrently mutated cancer genes |
Q34480870 | Learning regulatory programs by threshold SVD regression |
Q35579716 | MicroRNAs are part of the regulatory network that controls EGF induced apoptosis, including elements of the JAK/STAT pathway, in A431 cells |
Q36188413 | MinePath: Mining for Phenotype Differential Sub-paths in Molecular Pathways. |
Q35850350 | Modeling cancer metabolism on a genome scale |
Q34434094 | MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. |
Q89944347 | Network Properties of Cancer Prognostic Gene Signatures in the Human Protein Interactome |
Q55209361 | Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma. |
Q64058608 | NoMAS: A Computational Approach to Find Mutated Subnetworks Associated With Survival in Genome-Wide Cancer Studies |
Q33731252 | On the performance of de novo pathway enrichment. |
Q36675479 | Particulate Air Pollution Exposure and Expression of Viral and Human MicroRNAs in Blood: The Beijing Truck Driver Air Pollution Study |
Q28914768 | Pathway and network analysis of cancer genomes |
Q59137957 | Pathway-based subnetworks enable cross-disease biomarker discovery |
Q30869262 | Predicting cancer prognosis using functional genomics data sets. |
Q52644178 | Protein S-Nitrosylation Controls Glycogen Synthase Kinase 3β Function Independent of its Phosphorylation State |
Q39665946 | Protein interaction network (PIN)-based breast cancer subsystem identification and activation measurement for prognostic modeling |
Q30859718 | ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis |
Q92203211 | Regulostat Inferelator: a novel network biology platform to uncover molecular devices that predetermine cellular response phenotypes |
Q47103384 | Robust method for identification of prognostic gene signatures from gene expression profiles. |
Q33836622 | Selecting biologically informative genes in co-expression networks with a centrality score |
Q92971911 | Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers |
Q27499832 | The `dnet’ approach promotes emerging research on cancer patient survival |
Q41612655 | The landscape of DNA methylation-mediated regulation of long non-coding RNAs in breast cancer. |
Q30973696 | Tools for visualization and analysis of molecular networks, pathways, and -omics data |
Q28586338 | Total particulate matter concentration skews cigarette smoke's gene expression profile |
Q42282780 | Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma |
Q35740145 | Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy |
Q57295441 | Typing tumors using pathways selected by somatic evolution |
Q26750460 | Use of systems biology to decipher host-pathogen interaction networks and predict biomarkers |
Q35017720 | Using random walks to identify cancer-associated modules in expression data |
Q28658946 | t4 workshop report: Pathways of Toxicity |
Search more.